What Does Implantica Do?

Total employees65
HeadquartersBaar
Founded2003

Implantica AG is a medical technology group dedicated to bringing advanced technology into the body. Its lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux disease (GERD) that has the potential to create a new standard in anti-reflux surgery. Implantica is focused on developing a portfolio of 'smart' implants, utilizing wireless energy transfer and e-health connectivity, to address significant unmet medical needs and enhance patient quality of life through innovative solutions.

Where Is Implantica's Headquarters?

HQ Function

The Swiss headquarters serves as the central hub for Implantica's global operations, including strategic leadership, corporate finance, investor relations, and oversight of research, development, and commercialization efforts.

Notable Features:

The headquarters likely features modern office facilities conducive to innovation and collaboration, situated within a professional business environment typical of Baar.

Work Culture:

Implantica's work culture is expected to be driven by innovation, precision, and a strong ethical commitment to improving patient outcomes, fostering a collaborative environment for its specialized medtech professionals.

HQ Significance:

Locating the headquarters in Switzerland underscores Implantica's commitment to high-quality standards, precision engineering, and access to a robust European medtech ecosystem and financial markets.

Values Reflected in HQ: The headquarters' location and operations aim to reflect Implantica's core values of innovation, excellence, patient-centricity, and integrity in the medical technology field.

Location:

Implantica supports its global aspirations through its headquarters in Switzerland and key operational offices in Liechtenstein and Germany. Its primary functions supported globally include research and development, clinical trial management, manufacturing oversight, regulatory affairs, and the commercialization of its innovative medical implants like RefluxStop™. The company is actively expanding its market presence, particularly in Europe, with a strategy for broader international market entry.

Street Address:

Gewerbestrasse 16

City:

Baar

State/Province:

Zug

Country:

Switzerland

Where Else Does Implantica Operate Around the World?

Ruggell, Liechtenstein

Address: Industriering 14, LI-9491 Ruggell

Facilitates Implantica's commercial operations and market access, leveraging Liechtenstein's specific business and regulatory environment for international trade in the medical device sector.

Düsseldorf, Germany

Address: Graf-Adolf-Platz 15, 40213 Düsseldorf

Strengthens Implantica's presence in a key European medtech market, supporting clinical activities, regulatory engagement, and business development within Germany and the EU.

Buying Intent Signals for Implantica

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Implantica? Meet the Executive Team

As of April 2025, Implantica' leadership includes:

Peter Forsell - Founder, CEO and Board Member
Andreas Öhrnberg - Chief Financial Officer (CFO)
Nicole Pehrsson - Head of Clinical, Regulatory & Quality
Roger Maret - Head of Sales
Will Shannon - Head of Implantica UK and Ireland

Who's Investing in Implantica?

Implantica has been backed by several prominent investors over the years, including:

Peter Forsell (Principal Shareholder via wholly owned companies)
Publicly Traded on Nasdaq First North Premier Growth Market (Ticker: IMP A SDB)
Handelsbanken Fonder
Swedbank Robur Fonder
Fjärde AP-fonden (Fourth Swedish National Pension Fund)

What Leadership Changes Has Implantica Seen Recently?

Hire1
Exits1

In the past 12 months, Implantica has seen a key leadership transition in its commercial team with the appointment of a new Head of Sales, Roger Maret, following the departure of the former Chief Commercial Officer. This change aligns with the company's focus on strengthening its sales and market penetration efforts for products like RefluxStop™.

Departures

Maurice NAbET, Maurice NAbET departed from his role as Chief Commercial Officer, concluding his tenure in leading the company's commercial strategy.

New Appointments:

Roger Maret, Roger Maret was appointed as the new Head of Sales, bringing his expertise to drive Implantica's sales growth and market expansion.

What Technology (Tech Stack) Is Used byImplantica?

Discover the tools Implantica uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Implantica Email Formats and Examples

Implantica commonly uses the [first name].[last name]@implantica.com email format for its employees. This is a standard professional email structure, facilitating communication with company representatives.

[first].[last]@implantica.com

Format

peter.forsell@implantica.com

Example

90%

Success rate

What's the Latest News About Implantica?

Implantica Website / GlobeNewswireJune 4, 2024

Implantica Secures RefluxStop™ Reimbursement Approval from DAK-Gesundheit, a Major German Insurer

Implantica announced that DAK-Gesundheit, one of Germany's largest statutory health insurance companies, has approved reimbursement for its RefluxStop™ device. This significantly expands patient access to the innovative acid reflux treatment in Germany....more

Implantica Website / GlobeNewswireMay 15, 2024

Implantica Publishes Interim Report Q1 January-March 2024

Implantica released its financial results for the first quarter of 2024, highlighting ongoing sales momentum for RefluxStop™, progress in market expansion, and updates on its operational and clinical activities. The report detailed revenue figures and the company's financial position....more

Implantica Website / GlobeNewswireApril 16, 2024

Implantica Publishes Annual Report for 2023

Implantica released its comprehensive Annual Report for the fiscal year 2023. The report summarized the company's financial performance, key strategic achievements including the commercialization of RefluxStop™, research and development milestones, and outlined its strategic outlook for future growth....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Implantica, are just a search away.